Matt Callahan is a Perth-raised biotechnology executive currently based in Pennsylvania, USA. He is an executive director at ASX-listed Botanix Pharmaceutical and unlisted company Respirion Pharmaceutical. Mr Callahan remains a partner at Stone Ridge Ventures, a seed stage venture capital fund based in Perth. He won a 40under40 award as as the business development director of QPSX. Mr. Callahan has a Bachelor of Laws (Honours) from the University of WA and an MBA.
Bio last updated 30 Nov 2019
BNiQ Network Graph
Displaying all related organisations and their related contacts. Hover over a node to display a link to the BNiQ page for that person or organisation.
Access to our data for Matt Callahan is only available to paid subscribers with BNiQ access.
The BNiQ search engine is Western Australia's most accurate and comprehensive business listings and searchable database.
Matt Callahan is linked to 10 organisations which are included in 2 lists - Fund Managers and Public Companies - Industrial.
To see the data you will need to subscribe.
All 40under40 winners for 2002